⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

December 17, 2010Expert Review of Anticancer TherapyOpen Access

Serum tumor markers and their utilization in the management of germ-cell tumors in adult males

Mohamed E. Salem Timothy D. Gilligan

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

One of the factors that helped improve the management of testicular germ-cell tumors (GCTs) was the introduction of serum tumor markers (STMs). GCTs are associated with two highly specific and sens...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Salem et al. (2010) studied this question.

synapsesocial.com/papers/6aaa0a4c9165e02198fc9300 https://doi.org/10.1586/era.10.219

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Differences in Recognition of the 1st WHO International Reference Reagents for hCG-Related Isoforms by Diagnostic Immunoassays for Human Chorionic GonadotropinOriginal Research · 2009 · 123 citations
2Free β-Subunit of Human Chorionic Gonadotropin in Serum Is a Diagnostically Sensitive Marker of Seminomatous Testicular CancerDiagnostic Study · 2008 · 54 citations
3National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Clinical Practice: Quality Requirements1Original Research · 2008 · 168 citations
4False-Positive Serum Human Chorionic Gonadotropin (hCG) in a Male Patient with a Malignant Germ Cell Tumor of the Testis: A Case Report and Review of the LiteratureCase Report · 2008 · 25 citations
5American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell TumorsClinical Guideline · 2010 · 298 citations
6International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.Prognostic Study · 1997 · 1,970 citations
7Trastuzumab deruxtecan in HER2-expressing urothelial carcinoma: current evidence, biomarker challenges, and future therapeutic strategiesExpert Review of Anticancer Therapy · 2026
8Biological state–guided oncology: a framework for dynamic precision cancer care through oncological state transitionsExpert Review of Anticancer Therapy · 2026
9TROP2-directed antibody-drug conjugates (ADCs) challenge of predicting clinical outcomeExpert Review of Anticancer Therapy · 2026
10Survivorship in gynecological cancers: addressing psychosocial and physical challengesExpert Review of Anticancer Therapy · 2026

More from Expert Review of Anticancer Therapy

More from Cleveland Clinic